ClinicalTrials.gg
CompletedNCT07767786Updated Aug 17, 2026

Effects of Pecha Kucha on Presentation Skills in Nursing Students

An interventional study of PowerPoint + Pecha Kucha summary and PowerPoint only in Nursing Education, Presentation Skills and Pecha Kucha, sponsored by Izmir Katip Celebi University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by Izmir Katip Celebi University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 3 years 4 months after the study started (first participant enrolled Mar 2023, registered Aug 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
272
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-14

Among 85 studies in Health Education with a site in Turkey — 10 open to participants now, 16 under way, none of them phase 3. Health Education · Turkey.

Enrollment
Largest of 79
272 · median 100
Started
2023
with 12 others
No phase
79 of 85
10 open now
Registered
78th of 85
by date
Lead sponsor
2 of 85
Izmir Katip Celebi University

Among the 85 studies in Health Education with a site in Turkey, this one has the largest enrollment of the 79 interventional ones that give a count, is one of 13 that started in 2023, is one of 79 with no phase, and was the 78th registered.

Health Education

483 studies on the registry are indexed under Health Education; 112 are open to participants now.

Browse Health Education studies →

Open to participants now

10 of the 85 studies in Health Education with a site in Turkey are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 46 Health Education studies recruiting now, 29 (63%) set no upper age limit and 14 (30%) stop at 75 or younger; 11 take children under 18; 18 take healthy volunteers.

This study: 18 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 85 studies in Health Education with a site in Turkey, or all of them as a file.
02

Study summary

Background: Pecha Kucha may support concise and organized health education presentations, but its contribution when added to conventional PowerPoint presentations remains unclear.

Method: In this randomized, posttest-only controlled study, 272 first-year nursing students were assigned to PowerPoint-only or PowerPoint-plus-Pecha Kucha groups. Presentation skills, motivation, and satisfaction were assessed after the presentations.

03

Conditions studied

  • Nursing Education
  • Presentation Skills
  • Pecha Kucha

Browse trials for

Keywords

  • Health Education
  • Nursing Education
  • Nursing Students
  • Pecha Kucha
  • Presentation Skills
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • First-year nursing students enrolled in the Healthy Living and Nursing Course during the study period.
  • Voluntary participation in the study and provision of .
  • No previous structured training in the Pecha Kucha presentation technique.
  • Completion of the assigned presentation and post-intervention data collection forms.

Exclusion criteria

Exclusion Criteria:

  • Not participating in the assigned presentation.
  • Withdrawal from the study at any stage.
  • Incomplete completion of the data collection instruments.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
272 participants (actual)

Study arms

  • Experimental
    PowerPoint + Pecha Kucha summary

    Participants received a 25-minute structured training session on the Pecha Kucha presentation technique. They then prepared and delivered a 25-minute PowerPoint presentation on an assigned health education topic, followed by a 6-minute 40-second Pecha Kucha summary consisting of 20 slides displayed for 20 seconds each.

    Other: PowerPoint + Pecha Kucha summary

  • Active comparator
    PowerPoint only

    Participants prepared and delivered a conventional 25-minute PowerPoint presentation on the assigned health education topic. They did not receive Pecha Kucha training or use the Pecha Kucha presentation format during the study.

    Other: PowerPoint only

Interventions

  • OtherPowerPoint + Pecha Kucha summary

    Participants received a 25-minute structured training session on the Pecha Kucha presentation technique. The training included the purpose and principles of Pecha Kucha, the 20 × 20 format, automatic slide progression, visual slide preparation, timing, and presentation delivery. Participants then prepared and delivered a 25-minute PowerPoint presentation on an assigned health education topic, followed by a 6-minute 40-second Pecha Kucha summary consisting of 20 slides displayed for 20 seconds each.

  • OtherPowerPoint only

    Participants prepared and delivered a conventional 25-minute PowerPoint presentation on the assigned health education topic. No Pecha Kucha training was provided, and the Pecha Kucha presentation format was not used during the study.

06

What researchers measure

Primary outcomes

  1. Presentation Skills Assessed With the Presentation Skills Assessment Form (PSAF)

    Presentation skills were assessed using the Presentation Skills Assessment Form (PSAF), which consists of 25 items scored as 0, 2, or 4. Total scores range from 0 to 100, with higher scores indicating better presentation skills.

    Time frame: Immediately post-intervention

Secondary outcomes

  1. Motivation Assessed With the Instructional Materials Motivation Survey (IMMS)

    Motivation was assessed using the Instructional Materials Motivation Survey (IMMS), which consists of 24 items rated on a five-point Likert scale. Total scores range from 24 to 120, with higher scores indicating greater motivation toward the instructional material.

    Time frame: Immediately post-intervention

  2. Satisfaction With the Presentation Method Assessed Using a Visual Analog Scale (VAS)

    Satisfaction with the presentation method was assessed using a Visual Analog Scale (VAS) ranging from 0 ("not satisfied at all") to 10 ("very satisfied"), with higher scores indicating greater satisfaction.

    Time frame: Immediately post-intervention

07

Study locations

1 site
  • Ege Universty
    Izmir, Bornova 35000, Turkey (Türkiye)
08

References and documents

Publications

  • Google Scholar

Related links

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared due to participant confidentiality and ethical considerations. De-identified data may be made available from the corresponding author upon reasonable request, subject to institutional and ethical approval.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2023 to primary completion in Jun 2024, 15 months.

Of 292 non-industry interventional studies with no phase under Health Education, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 24. This study's 15 months is above that.

Counting every sponsor, half of 293 studies reached it within 11 months; a quarter within 3 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 11, 2026
First posted
Aug 17, 2026
StartActual
Mar 13, 2023
Primary completionActual
Jun 30, 2024
CompletionActual
Aug 30, 2024
Last update
Aug 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07767786
Responsible party
Devrim Özge YILMAZ (Principal Investigator, Izmir Katip Celebi University) — Principal investigator
First posted
Aug 17, 2026
Start date
Mar 13, 2023
Primary completion
Jun 30, 2024
Completion
Aug 30, 2024
Last update
Aug 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion